Japanese squirrels may be a model for human amyloidosis

A research group led by Dr. Tomoaki Murakami from the Tokyo University of Agriculture and Technology has revealed that fibrinogen Aα-chain amyloidosis, a previously unreported disease in animals other than humans, is highly prevalent in Japanese squirrels (Sciurus lis). In this study, they compared the pathology with that of humans, and suggested the importance of Japanese squirrels in the comparative pathological analysis of fibrinogen Aα-chain amyloidosis.

The researchers published their results on August 8th in the Journal of Pathology.

Amyloidosis is a disease group in which amyloid, generated by misfolding of host proteins, deposits in several organs. Fibrinogen Aα-chain amyloidosis is an inherited disorder in which fibrinogen Aα-chain, a protein involved in blood coagulation, becomes amyloid and deposits in the renal glomeruli, resulting in renal failure. The disease was first reported in 1993, but a definitive treatment has not been established due to the small number of patients and many unknowns about the pathogenesis. In this study, they found that fibrinogen Aα-chain amyloidosis occurs extremely frequently in Japanese squirrels, and compared the pathogenesis of this disease with that in humans.

The research team first conducted histopathological analysis on the whole body organs of a total of 38 captive Japanese squirrels that died at five zoos in Japan between 2018 and 2022, and found that 29 cases (76.3%) had suffered systemic amyloidosis characterized by severe glomerular amyloid deposition.

I was amazed because it is rare to see such a high incidence of amyloidosis in one animal species."

Susumu Iwaide, first author and graduate student in Laboratory of Veterinary Toxicology at TUAT

They performed mass spectrometry-based proteomic analysis and immunohistochemistry, and identified fibrinogen Aα-chain as a precursor protein. "Interestingly, amyloid exclusively deposited in the glomeruli but not in the tubulointerstitium in the affected kidney, which is same as the human condition," said Iwaide.

Further analysis using mass spectrometry found that approximately 100 amino acids in the C-terminal region of the fibrinogen Aα-chain accumulate in amyloid deposits, which coincides with human disease. Gene analysis revealed no mutations in the amyloid-forming region between amyloidosis-affected and non-affected squirrels. Statistically, there was a significant association between the development of amyloidosis and aging. In addition, some affected individuals were close descendants of wild-protected squirrels. "We concluded that the reduced genetic diversity due to breeding in the zoo does not cause fibrinogen Aα-chain amyloidosis in Japanese squirrels, but an age-related disease inherent to the species," said Iwaide.

In human fibrinogen Aα-chain amyloidosis, mutations exist in the gene of the amyloid-forming region in individuals who develop the disease, leading to the change of the amino acid sequence. This indicates that the amino acid sequence of the C-terminal region of the fibrinogen Aα-chain is important for maintaining protein stability. Considering that the amyloid deposition pattern in the kidneys of Japanese squirrels was identical to that of human disease, fibrinogen Aα-chain seems to have a common mechanism of amyloid formation across animal species.

"The study of animal diseases is important not only for maintaining the health of wildlife and pets, but also for a better understanding of human pathology. Since fibrinogen Aα-chain amyloidosis in Japanese squirrels occurs at a very high frequency, we want to elucidate why Japanese squirrels are susceptible to fibrinogen Aα-chain amyloidosis in detail to develop treatments for the incurable human disease, as well as to maintain the health of Japanese squirrels," Iwaide added.

Journal reference:

Iwaide, S., et al. (2023) Fibrinogen Aɑ-chain amyloidosis outbreaks in Japanese squirrels (Sciurus lis): a potential disease model. The Journal of Pathology. doi.org/10.1002/PATH.6150.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Omics-based approaches to age-related macular degeneration